Longeveron LGVN
NASDAQ LGVN
$3.30 +0.46 (+16.20%)
At close: Nov 11, 2026 · 4:00 PM EST

Longeveron (LGVN) Current Leases (2022 - 2026)

Updated

Analysis

Longeveron (LGVN) Current Leases (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Longeveron 8.60 Mn -31.21 Mn 182,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 688,000.00
Dec 31, 2025 655,000.00
Dec 31, 2024 623,000.00
Dec 31, 2023 593,000.00
Dec 31, 2022 564,000.00
API Access

Longeveron Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=LGVN&period=max&api_key=YOUR_API_KEY